Literature DB >> 23114761

Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.

Jorge Meneses Nunes1, Fernando César Bizerra, Renata Carmona E Ferreira, Arnaldo Lopes Colombo.   

Abstract

Rhodotorula species are emergent fungal pathogens capable of causing invasive infections, primarily fungemia. They are particularly problematic in immunosuppressed patients when using a central venous catheter. In this study, we evaluated the species distribution of 51 clinical and 8 environmental Rhodotorula species isolates using the ID32C system and internal transcribed spacer (ITS) sequencing. Antifungal susceptibility testing and biofilm formation capability using a crystal violet staining assay were performed. Using ITS sequencing as the gold standard, the clinical isolates were identified as follows: 44 R. mucilaginosa isolates, 2 R. glutinis isolates, 2 R. minuta isolates, 2 R. dairenensis isolates, and 1 Rhodosporidium fluviale isolate. The environmental isolates included 7 R. mucilaginosa isolates and 1 R. slooffiae isolate. Using the ID32C system, along with a nitrate assimilation test, only 90.3% of the isolates tested were correctly identified. In the biofilm formation assay, R. mucilaginosa and R. minuta exhibited greater biofilm formation ability compared to the other Rhodotorula species; the clinical isolates of R. mucilaginosa showed greater biofilm formation compared to the environmental isolates (P = 0.04). Amphotericin B showed good in vitro activity (MIC ≤ 1 μg/ml) against planktonic cells, whereas voriconazole and posaconazole showed poor activity (MIC(50)/MIC(90), 2/4 μg/ml). Caspofungin and fluconazole MICs were consistently high for all isolates tested (≥64 μg/ml and ≥ 4 μg/ml, respectively). In this study, we emphasized the importance of molecular methods to correctly identify Rhodotorula species isolates and non-R. mucilaginosa species in particular. The antifungal susceptibility profile reinforces amphotericin B as the antifungal drug of choice for the treatment of Rhodotorula infections. To our knowledge, this is the first study evaluating putative differences in the ability of biofilm formation among different Rhodotorula species.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23114761      PMCID: PMC3535921          DOI: 10.1128/AAC.01647-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts.

Authors:  D E Ciardo; G Schär; E C Böttger; M Altwegg; P P Bosshard
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples.

Authors:  F Galán-Sánchez; P García-Martos; C Rodríguez-Ramos; P Marín-Casanova; J Mira-Gutiérrez
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

3.  Infection by Rhodotorula sp. in children receiving treatment for malignant diseases.

Authors:  Gilberto Comarú Pasqualotto; Felipe Antônio Copetti; Clarice Franco Meneses; Adão Rogério Leal Machado; Algemir Lunardi Brunetto
Journal:  J Pediatr Hematol Oncol       Date:  2005-04       Impact factor: 1.289

4.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

5.  [Carbohydrate assimilation by clinical and environmental Rhodotorula glutinis strains].

Authors:  Pedro García-Martos; Lidia García-Agudo; Jesús Ruiz-Aragón; Abel Saldarreaga; Pilar Marín
Journal:  Rev Iberoam Micol       Date:  2004-06       Impact factor: 1.044

6.  [Evaluation of the API20C AUX system for the identification of clinically important yeasts].

Authors:  Jaqueline Otero Silva; Regina Célia Candido
Journal:  Rev Soc Bras Med Trop       Date:  2005-05-04       Impact factor: 1.581

7.  Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review.

Authors:  Alicia Gomez-Lopez; Emilia Mellado; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  J Antimicrob Chemother       Date:  2005-02-04       Impact factor: 5.790

Review 8.  Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature.

Authors:  G Samonis; M Anatoliotaki; H Apostolakou; S Maraki; D Mavroudis; V Georgoulias
Journal:  Infection       Date:  2001 May-Jun       Impact factor: 3.553

9.  [Yeast carriage on the hands of Medicine students].

Authors:  Víctor Silva; Guillermo Zepeda; María Eugenia Rybak; Naldy Febré
Journal:  Rev Iberoam Micol       Date:  2003-06       Impact factor: 1.044

10.  Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.

Authors:  Aimee K Zaas; Molly Boyce; Wiley Schell; Barbara Alexander Lodge; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

View more
  27 in total

1.  Molecular identification and antifungal susceptibility testing of Pucciniomycotina red yeast clinical isolates from Rio de Janeiro, Brazil.

Authors:  Fabio Brito-Santos; Maria Helena Galdino Figueiredo-Carvalho; Rowena Alves Coelho; Jean Carlos Almeida de Oliveira; Raissa Vieira Monteiro; Alessandra Leal da Silva Chaves; Rodrigo Almeida-Paes
Journal:  Braz J Microbiol       Date:  2019-11-27       Impact factor: 2.476

2.  Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.

Authors:  Maral Gharaghani; Simin Taghipour; Ali Zarei Mahmoudabadi
Journal:  Mol Biol Rep       Date:  2020-11-01       Impact factor: 2.316

Review 3.  New Perspectives on Antimicrobial Agents: Isavuconazole.

Authors:  James S Lewis; Nathan P Wiederhold; Morgan Hakki; George R Thompson
Journal:  Antimicrob Agents Chemother       Date:  2022-08-15       Impact factor: 5.938

4.  Rhodotorula mucilaginosa Fungemia, a Rare Opportunistic Infection without Central Venous Catheter Implantation, Successfully Treated by Liposomal Amphotericin B.

Authors:  Ryuichi Hirano; Tatsuro Mitsuhashi; Katsuyoshi Osanai
Journal:  Case Rep Infect Dis       Date:  2022-06-03

5.  Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.

Authors:  Laura Judith Marcos-Zambrano; Marta Gómez-Perosanz; Pilar Escribano; Oscar Zaragoza; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

6.  Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence.

Authors:  Lívia Custódio Pereira; Amabel Fernandes Correia; Zita Dinis Lopes da Silva; Ceres Nunes de Resende; Fabiana Brandão; Rosane Mansan Almeida; Yanna Karla de Medeiros Nóbrega
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-13       Impact factor: 3.267

Review 7.  Could Histoplasma capsulatum Be Related to Healthcare-Associated Infections?

Authors:  Laura Elena Carreto-Binaghi; Lisandra Serra Damasceno; Nayla de Souza Pitangui; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Rosely Maria Zancopé-Oliveira; Maria Lucia Taylor
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

8.  Catheter-Associated Rhodotorula mucilaginosa Fungemia in an Immunocompetent Host.

Authors:  Hyun Ah Kim; Miri Hyun; Seong-Yeol Ryu
Journal:  Infect Chemother       Date:  2013-09-27

9.  Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.

Authors:  Isabel Antonieta Iturrieta-González; Ana Carolina Barbosa Padovan; Fernando César Bizerra; Rosane Christine Hahn; Arnaldo Lopes Colombo
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

10.  Rhodotorula mucilaginosa, a quorum quenching yeast exhibiting lactonase activity isolated from a tropical shoreline.

Authors:  Norshazliza Ab Ghani; Joanita Sulaiman; Zahidah Ismail; Xin-Yue Chan; Wai-Fong Yin; Kok-Gan Chan
Journal:  Sensors (Basel)       Date:  2014-04-09       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.